Enimera – derived from Greek meaning ‘to inform’.

Enimera RegsPlus is a consultancy company formed around the principles of integrity, innovation, and commercial success.

Enimera RegsPlus was formed in 2018 with a vision to offer innovative yet pragmatic regulatory consulting service. From there, Enimera RegsPlus has expanded to also offer Pharmacovigilance and QA support. With great work comes great feedback and referrals, leading to expansion of the Enimera RegsPlus team.

Enimera RegsPlus is a consulting company providing superior Regulatory, Quality and Pharmacovigilance services to clients. Our clients range from start-ups to established organisations in the pharmaceutical, medical device, wellness, medicinal cannabis and food sectors. We are built on the values of integrity, innovation, and agility. Deliberately small and agile, the ERPPL team consists of high-performing individuals who align with these values and operate in a respectful, proactive and collaborative fashion to progress healthcare through serving our clients. Client activities span across prescription medicines, consumer medicines, medical devices and food.


Our Team

We pride ourselves on the values of integrity, innovation and agility. We can operate as an extension of your team, or as a discrete operating unit so your team to focus on the busines as usual.

Director – Mary Nteris, PhD, GAICD

Mary formed Enimera RegsPlus 2018 after 20+ years Regulatory experience in the Pharmaceutical/Clinical trials industry. She has held senior roles in biopharmaceutical, clinical research and wellness organisations, led teams and led strategic initiatives, having oversight of Regulatory services in Australia, New Zealand and Asia. She is a Life Member and former President of ARCS Australia, a guest-lecturer to a number of post-graduate courses, and a mentor to post-graduate students through the IMNIS program.

Mary holds a PhD in Pharmacology, and is a Guest Lecturer at a number of highly-regarded Australian universities.